- 商品介绍
- 规格参数
- 包装参数
Application
Functional Genomics/Screening/Target Validation
- Negative Control, CRISPR high titer lentivirus format.
To see more application data, protocols, vector maps visit sigma.com/crispr.
Features and Benefits
Serves as a negative experimental control for the CRISPR editing workflow using lenti CRISPR DNA.
Physical form
200 μl virus, minimum p24 titer > 5 x 108 TU/mL
Other Notes
This product is for R&D;use only, not for drug, household, or other uses. Please consult the Safety Data Sheet for information regarding hazards and safe handling practices. Though the lentiviral transduction particles produced are replication incompetent, it is recommended that they be treated as Risk Group Level 2 (RGL−2) organisms in laboratory handling. Follow all published RGL-2 guidelines for laboratory handling and waste decontamination.
Legal Information
CRISPR Use License Agreement
Lentiviral and WPRE License Agreements
| form | liquid |
| Quality Segment | 200 |
| packaging | vial of 200 μL |
| concentration | 5x108 VP/ml (via p24 assay) |
| application(s) | CRISPR |
| shipped in | dry ice |
| storage temp. | −70°C |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 1302.89
-
¥ 2019.57
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 238.17
-
询价
-
询价
-
¥ 4897.21
-
¥ 10277.12
-
¥ 4404.38
-
询价
-
¥ 2617.87
-
¥ 745.60
-
¥ 66743.99
-
¥ 64659.66
-
询价
微信小程序
7X24小时在线咨询